4//SEC Filing
YAU YI CHING 4
Accession 0000899243-19-027431
CIK 0001743881other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 7:21 PM ET
Size
8.1 KB
Accession
0000899243-19-027431
Insider Transaction Report
Form 4
YAU YI CHING
Chief Accounting Officer
Transactions
- Award
Restricted Stock Units
2019-11-13+20,376→ 20,376 total→ Common Stock (20,376 underlying) - Award
Stock Option (Right to Buy)
2019-11-13+78,148→ 78,148 totalExercise: $26.28Exp: 2029-11-12→ Common Stock (78,148 underlying)
Footnotes (3)
- [F1]The option shall vest and become exercisable as to 25% of the shares on October 7, 2020, and as to 1/48th of the shares each month thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
- [F2]Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date.
- [F3]The units shall vest as to 25% of the units on November 16, 2020, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001790097
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 7:21 PM ET
- Size
- 8.1 KB